- Report
- December 2023
- 365 Pages
Global
From €4008EUR$4,200USD£3,358GBP
- Report
- February 2024
- 109 Pages
Global
From €4252EUR$4,455USD£3,562GBP
€4724EUR$4,950USD£3,958GBP
- Report
- December 2023
- 192 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- October 2023
- 154 Pages
Global
From €4438EUR$4,650USD£3,718GBP
- Report
- October 2023
- 173 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2023
- 170 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- April 2023
- 111 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- June 2022
- 130 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- October 2023
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- July 2024
- 125 Pages
From €3293EUR$3,450USD£2,759GBP
- Report
- April 2022
- 212 Pages
Global
From €3436EUR$3,600USD£2,879GBP
- Report
- August 2024
- 91 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2023
- 92 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- August 2023
- 123 Pages
Global
From €3500EUR$3,929USD£3,035GBP

The PCR Reagent market within the biotechnology industry is a rapidly growing sector, driven by the increasing demand for accurate and reliable diagnostic tests. PCR reagents are used in a variety of applications, including the detection of genetic mutations, the identification of pathogens, and the quantification of gene expression. The market is expected to continue to grow as the demand for more sophisticated and accurate diagnostic tests increases.
The PCR Reagent market is highly competitive, with a number of major players offering a wide range of products. Prominent companies in the market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, Bio-Rad Laboratories, QIAGEN, and Promega Corporation. Show Less Read more